MOACM
VIR icon

Mutual of America Capital Management’s Vir Biotechnology VIR Stock Holding History

Mutual of America Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
13,908
+990
+8% +$9.42K ﹤0.01% 1427
2026
Q1 		$116K Buy
12,918
+2,105
+19% +$16.8K ﹤0.01% 1345
2025
Q4 		$65.2K Buy
10,813
+232
+2% +$1.38K ﹤0.01% 1355
2025
Q3 		$60.4K Sell
10,581
-1,317
-11% -$6.73K ﹤0.01% 1348
2025
Q2 		$60K Sell
11,898
-1,539
-11% -$8.25K ﹤0.01% 1371
2025
Q1 		$87.1K Sell
13,437
-540
-4% -$4.8K ﹤0.01% 1399
2024
Q4 		$103K Buy
13,977
+208
+2% +$1.64K ﹤0.01% 1428
2024
Q3 		$103K Sell
13,769
-544
-4% -$4.72K ﹤0.01% 1437
2024
Q2 		$127K Sell
14,313
-519
-3% -$4.98K ﹤0.01% 1430
2024
Q1 		$150K Sell
14,832
-237
-2% -$2.41K ﹤0.01% 1436
2023
Q4 		$152K Buy
15,069
+11
+0.1% +$101 ﹤0.01% 1431
2023
Q3 		$141K Buy
15,058
+142
+1% +$2.02K ﹤0.01% 1409
2023
Q2 		$366K Sell
14,916
-710
-5% -$17.8K ﹤0.01% 1226
2023
Q1 		$364K Sell
15,626
-275
-2% -$7.03K ﹤0.01% 1212
2022
Q4 		$402K Buy
15,901
+860
+6% +$21.1K 0.01% 1174
2022
Q3 		$290K Buy
15,041
+2,590
+21% +$65.8K ﹤0.01% 1241
2022
Q2 		$317K Buy
+12,451
New +$291K ﹤0.01% 1179

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mutual of America Capital Management's VIR Position: Q2 2026 in Review

Mutual of America Capital Management increased its Vir Biotechnology (VIR) stake by 7.7% in Q2 2026, buying an estimated $9.42K and bringing the position to 13,908 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Mutual of America Capital Management first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $402K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Mutual of America Capital Management held 13,908 shares of Vir Biotechnology worth $142K as of Q2 2026.
  • Mutual of America Capital Management bought 990 Vir Biotechnology shares in Q2 2026, an estimated $9.42K.
  • Vir Biotechnology made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1427 holding.
  • Mutual of America Capital Management first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Mutual of America Capital Management's Vir Biotechnology position peaked at $402K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.